10-year survival of a patient with metastatic prostate cancer: Case report and literature review

  • Kristian Krpina | kristiank@net.hr Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Dean Markić Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Dražen Rahelić Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Juraj Ahel Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Nino Rubinić Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Josip Španjol Department of Urology, Clinical Hospital Center Rijeka, Rijeka, Croatia.

Abstract

Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2015-09-30
Info
Issue
Section
Case Reports - Prostate
Keywords:
Generalized lymphadenopathy, Prostate cancer, Survival, Treatment
Statistics
  • Abstract views: 2245

  • PDF: 751
  • SUPPLEMENTARY MATERIAL: 231
How to Cite
Krpina, K., Markić, D., Rahelić, D., Ahel, J., Rubinić, N., & Španjol, J. (2015). 10-year survival of a patient with metastatic prostate cancer: Case report and literature review. Archivio Italiano Di Urologia E Andrologia, 87(3), 252-253. https://doi.org/10.4081/aiua.2015.3.252